NCT01479946

Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin

An International Randomized Phase II Study Comparing Early Electrochemotherapy to Delayed or No Electrochemotherapy in Patients With Cutaneous Breast Cancer Metastases

• Status: Withdrawn
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Uppsala University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Electroporation combined with chemotherapy (ECT) has been shown to be an effective treatment for breast cancer that has spread to skin. In routine clinical practise, ECT is offered to patients when all other treatment options have been exhausted. This study tests the hypothesis that early treatment with ECT may result in improved local control of skin metastases, improved quality of life and reduced health care costs. Patients are randomised to either ECT given as early as possible in the course of the disease or delaying ECT for at least 6 months.

Conditions

• Breast Cancer
• Skin Metastases

Interventions

Type	Name	Description
DRUG	Electrochemotherapy	bleomycin together with electroporation

Timeline

• Start date: 2011-10-01
• Primary completion: 2014-12-01
• Completion: 2015-06-01
• First posted: 2011-11-28
• Last updated: 2014-12-09

Locations

1 site across 1 country: Sweden